Clinical trial Recruiting at 1 site Interventional Ages 16 to 65

Epidural electrical stimulation to restore function after T11–L3 spinal cord injury

Official title: Epidural Electrical Stimulation for Motor and Sensory Function Reconstruction in Spinal Cord Injury (T11-L3)

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT07207798 · Data updated 2026-11-12

This study will see if epidural electrical stimulation can help people with chronic T11–L3 spinal cord injuries (ASIA B–D) regain motor and sensory function.

Quick facts

Study typeInterventional
Ages16 Years to 65 Years
SexAll
Enrollment10 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedOctober 6, 2025
Trial IDNCT07207798 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with chronic T11–L3 spinal cord injury classified ASIA B–D, 2–24 months post-injury, WISCI II <13, medically fit for surgery and rehabilitation, and able to attend follow-up visits.

Probably not a fit

Patients unlikely to benefit include those outside the T11–L3 injury levels, with ASIA A complete injuries (not enrolled), severe comorbid neurological or psychiatric conditions, coagulation disorders, implanted cardiac devices, or inability to undergo surgery or rehabilitation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with chronic T11–L3 spinal cord injury (ASIA B–D) will undergo surgical implantation of an epidural electrical stimulation (EES) device followed by device activation and individualized programming. Outcomes including motor and sensory function and quality of life will be measured at baseline, immediately after activation, and at 1, 3, and 6 months post-implantation using standardized clinical tests, imaging (PET-CT, DTI), and electrophysiology (SEPs). All participants will receive standard rehabilitation alongside EES and regular follow-up for stimulation adjustments and assessments. The protocol targets people 2–24 months post-injury with limited ambulatory ability (WISCI II <13).

Why it matters

Potential benefit: If successful, EES could improve voluntary movement, sensation, and overall quality of life for people with mid- to lower-thoracic chronic spinal cord injuries.

How similar studies have gone: Previous small studies of epidural stimulation have shown promising but variable gains in voluntary movement and function, while larger confirmatory trials remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Spinal Cord Injury, ASIA B-D;
* Spinal cord injury levels at T11-L3;
* Diagnosed with spinal cord injury for ≥ 2 months and ≤ 24 months;
* WISCI II score \< 13;
* An expected survival period of ≥ 12 months.
* Subjects voluntarily participate in this study, sign the informed consent form, have good compliance, cooperate with necessary postoperative rehabilitation training and tests, and assist in follow-up visits.

Exclusion Criteria:

* Subjects with other severe organic neurological diseases, mental illnesses other than anxiety/depression.
* Subjects with hemorrhagic diathesis or coagulation dysfunction (prothrombin time \[PT\] ≥ 18 seconds).
* Subjects with a history of alcohol or drug abuse or dependence.
* Subjects with mental retardation, cognitive dysfunction, or personality disorders.
* Subjects with a history of electroconvulsive therapy or those requiring continuous electrotherapy.
* Subjects with implanted cardiac pacemakers, cardioverters, or defibrillators. Expected survival period \< 1 year.

Where it's running

  • Second Affiliated Hospital, School of Medicine, Zhejiang University
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: Junming Zhu — Second Affiliated Hospital, Zhejiang University, School of Medicine
  • Study coordinator: Junming Zhu
  • Email: dr.zhujunming@zju.edu.cn
  • Phone: 13968055768

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.